KLHL2

KLHL2 functions as a substrate-recognition adaptor for a CUL3-based E3 ubiquitin ligase complex, using its Kelch domain to capture specific substrates and direct their polyubiquitination and proteasomal degradation (PMID:23838290, PMID:33163274). Its best-characterized substrates are the WNK kinases: KLHL2 directly binds all four WNK isoforms and, together with CUL3, drives WNK4 ubiquitination and degradation (PMID:23838290). In vivo, this activity is physiologically selective — KLHL2-knockout mice accumulate WNK4 specifically in the renal medulla without activating the OSR1/SPAK-NCC phosphorylation cascade, distinguishing KLHL2's role from that of the paralog KLHL3 (PMID:28414128). KLHL2 sits downstream of CUL3 in this pathway: wild-type CUL3 promotes KLHL2 turnover, and an FHHt-associated CUL3 mutant accelerates KLHL2 degradation, while KLHL2 degrades wild-type but not disease-mutant WNK4 (PMID:26607111). Beyond the WNK axis, KLHL2 targets additional substrates through the same adaptor mechanism: it ubiquitinates UCK1 at lysine 81 for degradation — an activity antagonized by the deubiquitinase USP28 and tuned by ATM-dependent phosphorylation of both USP28 and UCK1 (PMID:31938050) — and it binds ARHGEF7 via its Kelch domain to promote its polyubiquitination and degradation, with Kelch-domain deletion abolishing both binding and degradation (PMID:33163274).

1. 2013 High

   Established that KLHL2 is a substrate adaptor for a CUL3 E3 ligase by identifying WNK kinases as its direct binding partners and degradation substrates, defining its core molecular activity.

   Evidence Co-IP, fluorescence correlation spectroscopy, and in vitro ubiquitination in HEK293T overexpression

   PMID:23838290

   Open questions at the time

   • Demonstrated in overexpression systems rather than at endogenous levels
   • Functional consequence of WNK degradation on downstream signaling not addressed here
2. 2015 Medium

   Placed KLHL2 within the FHHt pathway by showing CUL3 controls KLHL2 stability and that KLHL2 discriminates wild-type from disease-mutant WNK4, ordering the CUL3→KLHL2→WNK4 axis.

   Evidence HEK293 co-expression epistasis using FHHt-associated CUL3 and WNK4 disease mutants

   PMID:26607111

   Open questions at the time

   • Based on cell-based overexpression with disease mutants, not patient tissue
   • Mechanism by which mutant CUL3 accelerates KLHL2 degradation not resolved
3. 2017 High

   Confirmed KLHL2 as a physiological WNK4 regulator in vivo and defined its tissue specificity, distinguishing it functionally from KLHL3.

   Evidence KLHL2 knockout mouse with renal fractionation and immunoblotting for WNK4 and NCC/SPAK/OSR1 phosphorylation

   PMID:28414128

   Open questions at the time

   • Medulla-specific restriction of the phenotype not mechanistically explained
   • Physiological output of medullary WNK4 accumulation on renal function not characterized
4. 2020 High

   Expanded KLHL2's substrate range beyond WNK kinases and revealed a regulatory layer, showing site-specific UCK1 ubiquitination opposed by USP28 and modulated by ATM phosphorylation.

   Evidence Mass spectrometry, Co-IP, K81 site mutagenesis, and ubiquitination assays in AML cell lines and a murine AML model

   PMID:31938050

   Open questions at the time

   • How ATM-dependent phosphorylation switches USP28/UCK1 association is not structurally defined
   • Whether the WNK and UCK1 substrate pathways are co-regulated is unknown
5. 2020 Medium

   Identified ARHGEF7 as a further KLHL2 substrate and mapped substrate engagement to the Kelch domain, generalizing the adaptor mechanism across substrates.

   Evidence Co-IP, Kelch domain-deletion mutagenesis, and ubiquitination assay in renal carcinoma cell lines

   PMID:33163274

   Open questions at the time

   • Single lab; reciprocal in vivo confirmation absent
   • Downstream consequences of ARHGEF7 degradation on cell behavior not fully defined

• How KLHL2 substrate selection is governed across tissues and how its activity is integrated with upstream signaling remains unresolved.
• No structural model of the Kelch domain bound to any substrate
• Determinants of medulla-restricted WNK4 regulation not identified
• No unified picture linking the WNK, UCK1, and ARHGEF7 substrate programs